Human diversity of killer cell immunoglobulin-like receptors and disease

por Rajalingam, Raja
Publicado 2011

The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection

por Rajalingam, Raja
Publicado 2016

Allele-level HLA matching reduces early rejection in lung transplant recipients

por Rajalingam, Raja
Publicado 2020

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions

por Raghav, Pawan Kumar, Mann, Zoya, Ahluwalia, Simran Kaur, Rajalingam, Raja
Publicado 2023

KIR gene content diversity in four Iranian populations

por Ashouri, Elham, Farjadian, Shirin, Reed, Elaine F., Ghaderi, Abbas, Rajalingam, Raja
Publicado 2009

Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk

por Ashouri, Elham, Rajalingam, Karan, Barani, Shaghik, Farjadian, Shirin, Ghaderi, Abbas, Rajalingam, Raja
Publicado 2021

Hematopoietic Stem Cell Factors: Their Functional Role in Self-Renewal and Clinical Aspects

por Mann, Zoya, Sengar, Manisha, Verma, Yogesh Kumar, Rajalingam, Raja, Raghav, Pawan Kumar
Publicado 2022

Human-Specific Evolution and Adaptation Led to Major Qualitative Differences in the Variable Receptors of Human and Chimpanzee Natural Killer Cells

por Abi-Rached, Laurent, Moesta, Achim K., Rajalingam, Raja, Guethlein, Lisbeth A., Parham, Peter
Publicado 2010

Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression

por Gravina, Alessia, Tediashvili, Grigol, Rajalingam, Raja, Quandt, Zoe, Deisenroth, Chad, Schrepfer, Sonja, Deuse, Tobias
Publicado 2023

Short KIR Haplotypes in Pygmy Chimpanzee (Bonobo) Resemble the Conserved Framework of Diverse Human KIR Haplotypes

por Rajalingam, Raja, Hong, Mei, Adams, Erin J., Shum, Benny P., Guethlein, Lisbeth A., Parham, Peter
Publicado 2001

KIR-HLA gene diversities and susceptibility to lung cancer

por Hematian Larki, Marjan, Ashouri, Elham, Barani, Shaghik, Ghayumi, Seiyed Mohammad Ali, Ghaderi, Abbas, Rajalingam, Raja
Publicado 2022

Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations

por Raghav, Pawan Kumar, Raghav, Aditya, Lathwal, Anjali, Saxena, Archit, Mann, Zoya, Sengar, Manisha, Rajalingam, Raja
Publicado 2023

KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease

por Levinson, Ralph D., Yung, Madeline, Meguro, Akira, Ashouri, Elham, Yu, Fei, Mizuki, Nobuhisa, Ohno, Shigeaki, Rajalingam, Raja
Publicado 2016

COVID-19 does not impact HLA antibody profile in a series of waitlisted renal transplant candidates

por Roll, Garrett R., Lunow-Luke, Tyler, Braun, Hillary J., Buenaventura, Owen, Mallari, Mirelle, Stock, Peter G., Rajalingam, Raja
Publicado 2021

Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d(+) Antibody-Mediated Rejection in Kidney T...

por Tatapudi, Vasishta S., Kopchaliiska, Dessislava, da Gente, Gilberto J., Buenaventura, Owen F., Singh, Manpreet, Laszik, Zoltan, Adey, Deborah B., Rajalingam, Raja
Publicado 2021

Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma

por Sun, Haibo, Martin, Thomas G, Marra, John, Kong, Denice, Keats, Jonathon, Macé, Sandrine, Chiron, Marielle, Wolf, Jeffrey L, Venstrom, Jeffrey M, Rajalingam, Raja
Publicado 2021

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Trans...

por Faridi, Rehan Mujeeb, Kemp, Taylor J., Dharmani-Khan, Poonam, Lewis, Victor, Tripathi, Gaurav, Rajalingam, Raja, Daly, Andrew, Berka, Noureddine, Storek, Jan, Masood Khan, Faisal
Publicado 2016

Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19

por Maruthamuthu, Stalinraja, Rajalingam, Karan, Kaur, Navchetan, Morvan, Maelig G., Soto, Jair, Lee, Nancy, Kong, Denice, Hu, Zicheng, Reyes, Kevin, Ng, Dianna, Butte, Atul J., Chiu, Charles, Rajalingam, Raja
Publicado 2022

Allele-Level Haplotype Frequencies and Pairwise Linkage Disequilibrium for 14 KIR Loci in 506 European-American Individuals

por Vierra-Green, Cynthia, Roe, David, Hou, Lihua, Hurley, Carolyn Katovich, Rajalingam, Raja, Reed, Elaine, Lebedeva, Tatiana, Yu, Neng, Stewart, Mary, Noreen, Harriet, Hollenbach, Jill A., Guethlein, Lisbeth A., Wang, Tao, Spellman, Stephen, Maiers, Martin
Publicado 2012

Long-Term Safety, Immunologic Response, and Imaging Outcomes following Neural Stem Cell Transplantation for Pelizaeus-Merzbacher Disease

por Gupta, Nalin, Henry, Roland G., Kang, Sang-Mo, Strober, Jonathan, Lim, Daniel A., Ryan, Tamara, Perry, Rachel, Farrell, Jody, Ulman, Mary, Rajalingam, Raja, Gage, Allyson, Huhn, Stephen L., Barkovich, A. James, Rowitch, David H.
Publicado 2019